Tandem Diabetes Care (TNDM) EPS (Basic) Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 5.98% |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn | 46.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.14% |
| Dec 31, 2025 | 65.80% |
| Sep 30, 2025 | 25.84% |
| Jun 30, 2025 | -50.24% |
| Mar 31, 2025 | -104.60% |
| Dec 31, 2024 | -61.11% |
| Sep 30, 2024 | -80.58% |
| Jun 30, 2024 | -114.24% |
| Mar 31, 2024 | -101.04% |
| Dec 31, 2023 | -54.72% |
| Sep 30, 2023 | -50.37% |
| Jun 30, 2023 | -6.92% |
| Mar 31, 2023 | -97.30% |
| Dec 31, 2022 | -102.06% |
| Sep 30, 2022 | -147.71% |
| Jun 30, 2022 | -97.18% |
| Mar 31, 2022 | 16.84% |
| Dec 31, 2021 | 41.50% |
| Sep 30, 2021 | 28.97% |
| Jun 30, 2021 | 27.06% |